Standard Epilepsy Treatments During Pregnancy
Lacosamide (Vimpat) is used for partial-onset seizures but lacks extensive pregnancy safety data, with animal studies showing fetal risks and limited human outcomes.[1] Guidelines from the American Academy of Neurology (AAN) and American College of Obstetricians and Gynecologists (ACOG) recommend alternatives with stronger evidence for monotherapy in women of childbearing potential.[2]
Preferred Alternatives for Seizure Control
Lamotrigine and levetiracetam top recommendations due to lower malformation risks (2-3% vs. 4-10% for older drugs like valproate).[2][3]
- Lamotrigine: First-line for focal and generalized seizures; crosses placenta but breastfeeding-compatible; dose adjustments needed in pregnancy due to metabolism changes.[3]
- Levetiracetam: Broad efficacy for focal seizures; minimal teratogenicity (1.5-2% risk); no major congenital issues in registries like EURAP.[2][4]
Other Viable Options and Comparisons
| Drug | Malformation Risk | Key Pregnancy Notes | vs. Lacosamide |
|------|-------------------|---------------------|---------------|
| Oxcarbazepine | 2-3% | Similar to lamotrigine; monitor folate | Better data; less neural tube risk |
| Topiramate | 3-4% | Cleft lip/palate risk; weight loss side effect | Avoid if possible; lacosamide has less cleft data |
| Valproate | 10%+ | Highest risk (neural tube defects); contraindicated | Far riskier than lacosamide |
| Carbamazepine | 4-6% | Folate supplementation required | Older, more enzyme induction |
Lacosamide shows no clear malformation signal in small cohorts (e.g., ~1% above baseline), but registries like UK/Epilepsy Pregnancy Register urge caution due to sparse data.[1][5]
Why Switch Before or During Pregnancy?
Preconception counseling prioritizes lowest-risk drugs to minimize teratogenicity, cognitive risks, and neonatal withdrawal. Valproate bans in many guidelines highlight this shift.[2] Lacosamide's FDA Pregnancy Category C (animal risks, inadequate human studies) pushes toward Category B options like lamotrigine.[6]
Risks of Untreated Seizures vs. Meds
Status epilepticus harms fetus (hypoxia, mortality up to 10%); well-controlled epilepsy on safe AEDs has better outcomes than frequent seizures.[3] Folic acid 4mg daily reduces neural tube defects across all regimens.[2]
Non-Drug Alternatives